{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T10:50:19Z","timestamp":1759229419253},"reference-count":20,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1016\/j.ijcard.2003.03.022","type":"journal-article","created":{"date-parts":[[2004,3,5]],"date-time":"2004-03-05T10:49:05Z","timestamp":1078483745000},"page":"193-196","source":"Crossref","is-referenced-by-count":5,"title":["Pericardial fluid and serum VEGF in response to different types of heparin treatment"],"prefix":"10.1016","volume":"94","author":[{"given":"Rabin","family":"Gerrah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sagi","family":"Tshori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Gilon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2003.03.022_BIB1","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.1161\/01.CIR.96.11.4083","article-title":"Modulation of growth factor action: implication for the treatment of cardiovascular diseases","volume":"96","author":"Waltenberger","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2003.03.022_BIB2","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/362801a0","article-title":"The pathogenesis of atherosclerosis: a prospective for the 1990s","volume":"362","author":"Ross","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.ijcard.2003.03.022_BIB3","first-page":"1047","article-title":"Vascular endothelial growth factor (VEGF) and its effect on angiogenesis","volume":"6","author":"Joko","year":"2000","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.ijcard.2003.03.022_BIB4","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1126\/science.2479986","article-title":"Vascular endothelial growth factor is a secreted angiogenic mitogen","volume":"246","author":"Leung","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.ijcard.2003.03.022_BIB5","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1073\/pnas.94.2.663","article-title":"Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets","volume":"94","author":"M\u00f6hle","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.ijcard.2003.03.022_BIB6","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1091\/mbc.3.2.211","article-title":"Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors","volume":"3","author":"Berse","year":"1992","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.ijcard.2003.03.022_BIB7","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/jlb.62.3.397","article-title":"Human neutrophils secrete vascular endothelial growth factor","volume":"62","author":"Taichman","year":"1997","journal-title":"J. Leukocyte Biol."},{"key":"10.1016\/j.ijcard.2003.03.022_BIB8","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1096\/fasebj.7.11.8370471","article-title":"Integral membrane heparan sulfate proteoglycans","volume":"7","author":"David","year":"1993","journal-title":"FASEB J."},{"key":"10.1016\/j.ijcard.2003.03.022_BIB9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0960-9822(98)70059-4","article-title":"Engineered mutants of HGF\/SF with reduced binding to heparan sulphate proteoglycans, decreased clearance and enhanced activity in vivo","volume":"29","author":"Hartmann","year":"1998","journal-title":"Curr. Biol."},{"issue":"2","key":"10.1016\/j.ijcard.2003.03.022_BIB10","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1006\/bbrc.1993.2144","article-title":"Hypoxia is a strong inducer of vascular endothelial growth factor mRNA expression in the heart","volume":"195","author":"Ladoux","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijcard.2003.03.022_BIB11","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1161\/01.RES.76.5.758","article-title":"Regulation of endothelial growth factor in cardiac myocytes","volume":"76","author":"Levy","year":"1995","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2003.03.022_BIB12","first-page":"1803","article-title":"VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis","volume":"270","author":"Li","year":"1996","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ijcard.2003.03.022_BIB13","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1152\/physrev.1991.71.2.481","article-title":"Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes","volume":"71","author":"Jackson","year":"1991","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ijcard.2003.03.022_BIB14","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1161\/01.CIR.88.1.198","article-title":"Heparin accelerates coronary collateral development in a porcine model of coronary artery occlusion","volume":"88","author":"Carroll","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2003.03.022_BIB15","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/01.CIR.77.5.1022","article-title":"Improvement of treadmill capacity and collateral circulation as a result of exercise with heparin pretreatment in patients with effort angina","volume":"77","author":"Fujita","year":"1988","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2003.03.022_BIB16","doi-asserted-by":"crossref","first-page":"64S","DOI":"10.1378\/chest.119.1_suppl.64S","article-title":"Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety","volume":"119","author":"Hirsh","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.ijcard.2003.03.022_BIB17","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJM199708143370702","article-title":"A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous. Enoxaparin in Non-Q-Wave Coronary Events Study Group","volume":"337","author":"Cohen","year":"1997","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.ijcard.2003.03.022_BIB18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1161\/01.CIR.96.1.61","article-title":"Comparison of low molecular weight heparin with UFH acutely and with placebo for 6 weeks in the management of unstable coronary artery disease: the Fragmin in Unstable Coronary Artery Disease study (FRIC)","volume":"96","author":"Klein","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2003.03.022_BIB19","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1006\/jmcc.1999.1062","article-title":"Elevation of vascular endothelial growth factor-A serum levels following acute myocardial infarction. Evidence for its origin and functional significance","volume":"32","author":"Kranz-Rau","year":"2000","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ijcard.2003.03.022_BIB20","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000007008","article-title":"Increased blood vascular endothelial growth factor levels in patients with acute myocardial infarction","volume":"93","author":"Ogawa","year":"2000","journal-title":"Cardiology"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527303003784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527303003784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T21:26:31Z","timestamp":1550179591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527303003784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":20,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["S0167527303003784"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2003.03.022","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4]]}}}